CymitQuimica logo

Hemopexin from human plasma

CAS:

Ref. 3D-JAA01371

1mg
Discontinued
5mg
Discontinued
10mg
Discontinued
25mg
Discontinued
50mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Hemopexin from human plasma
Biosynth

Product Information

Name:Hemopexin from human plasma
Brand:Biosynth
Description:Hemopexin is a glycoprotein that binds to and removes hemoglobin from plasma, thereby preventing the formation of hemosiderin. It has been shown to be an important component in the inflammatory response by binding to complement protein C3b. Hemopexin is also involved in the regulation of lipoprotein metabolism by binding to lipoproteins, such as Apo-E, and o-glycosylation. The glycosylation sites on hemopexin are the same as those found on other glycoproteins, such as transferrin and thrombospondin. Hemopexin's structure is characterized by two types of reactive groups: glcnac residues and fluorescent groups. These groups allow for labeling with various compounds and techniques, such as analytical chemistry or fluorescence spectroscopy.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Purity:Min. 95%

Inquiry about discontinued product: Hemopexin from human plasma

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.